2-Naphthoic Acid Ergosterol Ester, an Ergosterol Derivative, Exhibits Anti-Tumor Activity by Promoting Apoptosis and Inhibiting Angiogenesis

Mingzhu Lin,Haijun Li,Yan Zhao,Enbo Cai,Hongyan Zhu,Yugang Gao,Shuangli Liu,He Yang,Lianxue Zhang,Guosheng Tang
DOI: https://doi.org/10.1016/j.steroids.2017.03.007
IF: 2.76
2017-01-01
Steroids
Abstract:Phytosterol is a natural component of vegetable oil and includes ergosterol (ER) and β-sitosterol. In this study, three new ergosterol monoester derivatives were obtained from the reflux reaction with ergosterol, organic acids (furoic acid, salicylic acid, and 2-naphthoic acid), EDCI, and DMAP in dichloromethane. The chemical structures were defined by IR and NMR. On the basis of the results, 2-naphthoic acid ergosterol ester (NE) had the highest tumor inhibition rate and was selected to study anti-tumor activity and its mechanism at doses of 0.025mmol/kg and 0.1mmol/kg in H22-tumor bearing mice. Compared with ER, NE exhibited more stronger anti-tumor activity in vivo. Furthermore, biochemical parameters of ALT, AST, BUN, and CRE showed that NE had little toxicity to mice. NE significantly improved serum cytokine levels of IFN-γ and decreased VEGF levels. Moreover, H&E staining, TUNEL assay, immunohistochemistry, and western blotting indicated that NE exhibited anti-tumor activity in vivo by promoting apoptosis and inhibiting angiogenesis. In brief, the present study provided a method to improve ER anti-tumor activity and a reference for a new anti-tumor agent.
What problem does this paper attempt to address?